IL2 and neoplasm: Our group has previously shown that, surprisingly, the therapeutic effect of IL2-based immunocytokines against murine tumours is identical in immunocompetent and immunocompromised mice, and that NK cells are mainly responsible for the therapeutic action (Carnemolla et al, 2002; Halin et al, 2003; Ebbinghaus et al, 2005).